Dr. Carmen Espejo and Dr. Georgina Arrambide, researchers at Cemcat and Vall d'Hebron Research Institute, are the first authors of the article.
Supervised by Dr. Herena Eixarch and Dr. Carmen Espejo, the research work focuses on the aging of the immune system and its impact on the evolution of the disease.
Only 2.7% of the cohort analyzed had these antibodies, but they are very relevant for diagnosing and differentiating multiple sclerosis from the disease associated with anti-MOG antibodies (MOGAD).
